×
Back to Agenda
Has Decentralized Trials Crashed, or Are We Just Getting Started? An Inflection Point for Clinical Operations in Oncology
Session Chair(s)
Len Rosenberg, PHD, RPH
Head of Clinical Operations
Beat AML, A Division of Blood Cancer United, United States
Our industry is still mired in failing to adopt proven technology solutions until it becomes a reg necessity or mainstay of core operations. Industry change agents will present evidence that demonstrates we typically operate with lagging efforts.
Learning Objective : Identify emergent solutions and innovative business practices that can enhance clinical trial operations; Evaluate the impact of adopting decentralized trials in oncology using the Beat AML Master Trial as a case study; Discuss how risk-taking and cross-sector practices can accelerate clinical trial success and improve patient outcomes.
Speaker(s)
Panelist
Joseph Dustin
Dauntless Eclinical Strategies, United States
Founder and Principal
Have an account?